Novel immunotherapies in multiple myeloma - chances and challenges

被引：24
|
作者：
Rasche, Leo [1 ,2 ]
Wasch, Ralph [3 ]
Munder, Markus [4 ,5 ]
Goldschmidt, Hartmut [6 ,7 ]
Raab, Marc S. [6 ,8 ]
机构：
[1] Univ Hosp Wurzburg, Dept Internal Med 2, Wurzburg, Germany
[2] Univ Hosp Wurzburg, Mildred Scheel Early Career Ctr, Wurzburg, Germany
[3] Univ Freiburg, Fac Med, Univ Med Ctr, Dept Internal Med 1, Freiburg, Germany
[4] Johannes Gutenberg Univ Mainz, Univ Med Ctr, Dept Med 3, Mainz, Germany
[5] Johannes Gutenberg Univ Mainz, Univ Med Ctr, Res Ctr Immunotherapy, Mainz, Germany
[6] Univ Hosp Heidelberg, Dept Internal Med 5, Heidelberg, Germany
[7] Natl Ctr Tumor Dis NCT, Heidelberg, Germany
[8] German Canc Res Ctr, CCU Mol Hematol Oncol, Heidelberg, Germany
来源：
HAEMATOLOGICA | 2021年 / 106卷 / 10期
关键词：
T-CELL THERAPY; CAR-T; EXPRESSION; CD38;
D O I：
10.3324/haematol.2020.266858
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
In this review article, we summarize the latest data on antibody-drug conjugates, bispecific T-cell-engaging antibodies, and chimeric antigen receptor T cells in the treatment of multiple myeloma. We discuss the pivotal questions to be addressed as these new immunotherapies become standard agents in the management of multiple myeloma. We also focus on the selection of patients for these therapies and speculate as to how best to individualize treatment approaches. We see these novel immunotherapies as representing a paradigm shift. However, despite the promising preliminary data, many open issues remain to be evaluated in future trials.
引用
收藏
页码：2555 / 2565
页数：11
相关论文
共 50 条
  • [31] Advances in the Treatment of Relapsed and Refractory Multiple Myeloma in Patients with Renal Insufficiency: Novel Agents, Immunotherapies and Beyond
    Bozic, Boris
    Rutner, Jens
    Zheng, Chang
    Ruckser, Reinhard
    Selimi, Flonza
    Racz, Krysztina
    Koecher, Martin
    Tatzreiter, Georg
    Sebesta, Christian
    CANCERS, 2021, 13 (20)
  • [32] Mechanisms for resistance to BCMA-targeted immunotherapies in multiple myeloma
    Yue, Tingting
    Sun, Yue
    Dai, Yun
    Jin, Fengyan
    BLOOD REVIEWS, 2025, 70
  • [33] Touchless Interaction-Novel Chances and Challenges
    de la Barre, Rene
    Chojecki, Paul
    Leiner, Ulrich
    Muehlbach, Lothar
    Ruschin, Detlef
    HUMAN-COMPUTER INTERACTION, PT II: NOVEL INTERACTION METHODS AND TECHNIQUES, 2009, 5611 : 161 - 169
  • [34] Proteasome inhibition in combination with immunotherapies: State-of-the-Art in multiple myeloma
    Kegyes, David
    Gulei, Diana
    Drula, Rares
    Cenariu, Diana
    Tigu, Bogdan
    Dima, Delia
    Tanase, Alina
    Badelita, Sorina
    Buzoianu, Anca-Dana
    Ciurea, Stefan
    Ghiaur, Gabriel
    Terpos, Evangelos
    Ciechanover, Aaron
    Einsele, Hermann
    Tomuleasa, Ciprian
    BLOOD REVIEWS, 2023, 61
  • [35] The evolving status of immunotherapies in multiple myeloma: the future role of bispecific antibodies
    Swan, Dawn
    Routledge, David
    Harrison, Simon
    BRITISH JOURNAL OF HAEMATOLOGY, 2022, 196 (03) : 488 - 506
  • [36] T cell-based targeted immunotherapies for patients with multiple myeloma
    Wang, Lei
    Jin, Nan
    Schmitt, Anita
    Greiner, Jochen
    Malcherek, Georg
    Hundemer, Michael
    Mani, Jiju
    Hose, Dirk
    Raab, Marc S.
    Ho, Anthony D.
    Chen, Bao-an
    Goldschmidt, Hartmut
    Schmitt, Michael
    INTERNATIONAL JOURNAL OF CANCER, 2015, 136 (08) : 1751 - 1768
  • [37] Novel anti-myeloma immunotherapies targeting the SLAM family of receptors
    Radhakrishnan, Sabarinath Venniyil
    Bhardwaj, Neelam
    Luetkens, Tim
    Atanackovic, Djordje
    ONCOIMMUNOLOGY, 2017, 6 (05):
  • [38] Management of relapsed and refractory multiple myeloma: novel agents, antibodies, immunotherapies and beyond (vol 32, pg 252, 2018)
    Chim, C. S.
    Kumar, S. K.
    Orlowski, R. Z.
    Cook, G.
    Richardson, P. G.
    Gertz, M. A.
    Giralt, S.
    Mateos, M. V.
    Leleu, X.
    Anderson, K. C.
    LEUKEMIA, 2019, 33 (04) : 1058 - 1059
  • [39] CD155 on Multiple Myeloma Cells Is Epigenetically Regulated, Reduce Patients Survival and Compromises the Action of Novel Immunotherapies
    Martinez-Verbo, Laura
    Villanueva, Lorea
    Llinas-Arias, Pere
    Garcia-Prieto, Carlos Antonio
    Pineyro, David
    Oliver-Caldes, Aina
    Garcia-Ortiz, Almudena
    Valeri, Antonio
    Fernandez de Larrea, Carlos
    Martinez-Lopez, Joaquin
    Ferrer, Gerardo
    Esteller, Manel
    BLOOD, 2023, 142
  • [40] The serological diagnostic challenges of multiple myeloma
    Gu, Yisu
    Hunter, Terrence
    Offer, Mark
    BRITISH JOURNAL OF HOSPITAL MEDICINE, 2015, 76 (02) : 84 - 88
12345